Your session is about to expire
← Back to Search
Behavioral Intervention
Kinto Care Coaching for Dementia Caregivers
N/A
Waitlist Available
Research Sponsored by Kinto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes in unmet needs between the control and intervention conditions will be evaluated across time from t1 (baseline) to t2 (post-intervention completion/6-weeks from baseline) and t3 (45 days from t2
Awards & highlights
Study Summary
This trial explores if an intervention can help dementia caregivers with their caregiving goals & access to 1-on-1, support groups & digital resources. Researchers compare an intervention & control group to see if the program helps.
Who is the study for?
This trial is for adults over 18 in the U.S. who provide at least 5 hours of unpaid care weekly to a family member or friend with dementia and are fluent in English or Spanish. They must have a smartphone, internet, and email access. Those already in another non-drug study or involved with Kinto studies previously, or caring for someone with another caregiver in this study can't join.Check my eligibility
What is being tested?
The trial tests Kinto Care Coaching's effectiveness on caregivers' ability to meet general and financial caregiving goals through one-on-one coaching sessions, support groups, and digital resources via an app. It compares caregivers receiving the intervention against those who do not to assess its impact.See study design
What are the potential side effects?
Since this is a non-pharmacological intervention focusing on coaching and support rather than medication, traditional side effects are not expected; however, participants may experience emotional distress or fatigue related to discussing their caregiving experiences.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ changes in unmet needs between the control and intervention conditions will be evaluated across time from t1 (baseline) to t2 (post-intervention completion/6-weeks from baseline) and t3 (45 days from t2
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes in unmet needs between the control and intervention conditions will be evaluated across time from t1 (baseline) to t2 (post-intervention completion/6-weeks from baseline) and t3 (45 days from t2
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Caregiver Burden
Caregiver Mastery
Emotional Health Strain
+4 moreSecondary outcome measures
Anxiety
Behaviors - Distress
Behaviors - Frequency
+15 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention is a care coaching program that assists caregivers with their general caregiving goals and financial caregiving goals. Caregivers will attend a one-on-one care coaching session conducted via Zoom for 60-75 minutes with a care coach and will engage with their care coach through chat-based interactions after completing the session. If requested, up to two additional care coaching sessions will be scheduled.
Caregivers also will have the opportunity to attend up to 6 weekly support groups with other caregivers facilitated by a care coach and receive a variety of digital resources through the mobile app.
Group II: ControlActive Control1 Intervention
Control group that does not receive the Caregiver Support Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Kinto Care Coaching
2023
N/A
~500
Find a Location
Who is running the clinical trial?
Alzheimer's AssociationOTHER
92 Previous Clinical Trials
40,416 Total Patients Enrolled
KintoLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I provide at least 5 hours of care or support weekly.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger